MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar
Open accessThe DOI matches its Crossref record; 29 of the 32 references it cites were found in a registry or an index; 7 of the 14 sources its claims cite were checked for support.
Abstract
BACKGROUND: Extrapulmonary tuberculosis (EPTB) is a diagnostic challenge. An immunochemistry-based MPT64 antigen detection test (MPT64 test) has reported higher sensitivity in the diagnosis of EPTB compared with conventional methods. The objective of this study was to implement and evaluate the MPT64 test in routine diagnostics in a low-resource setting. METHODS: Patients with presumptive EPTB were prospectively enrolled at Mnazi Mmoja Hospital, Zanzibar, and followed to the end of treatment. Specimens collected were subjected to routine diagnostics, GeneXpert® MTB/RIF assay and the MPT64 test. The performance of the MPT64 test was assessed using a composite reference standard, defining the patients as tuberculosis (TB) cases or non-TB cases. RESULTS: Patients (n = 132) were classified as confirmed TB (n = 12), probable TB (n = 34), possible TB (n = 18), non-TB (n = 62) and uncategorized (n = 6) cases. Overall, in comparison to the composite reference standard for diagnosis, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the MPT64 test was 69%, 95%, 94%, 75% and 82%, respectively. The MPT64 test performance was best in TB lymphadenitis cases (n = 67, sensitivity 79%, specificity 97%) and in paediatric TB (n = 41, sensitivity 100%, specificity 96%). CONCLUSIONS: We show that the MPT64 test can be implemented in routine diagnostics in a low-resource setting and improves the diagnosis of EPTB, especially in TB lymphadenitis and in children.
Overview
CoChat Summary
## TL;DR
This prospective study at Zanzibar’s tertiary hospital evaluated an immunocytochemistry-based MPT64 antigen test for presumptive extrapulmonary tuberculosis (EPTB) in routine care. The test outperformed conventional methods and GeneXpert overall, with especially strong performance in TB lymphadenitis and in children.
## Key findings
- Among 132 enrolled patients, the CRS classified 12 as confirmed TB, 34 as probable TB, 18 as possible TB, 62 as non-TB, and 6 as uncategorized; 126 patients and 145 specimens were included in analysis.
- Overall MPT64 test performance versus the composite reference standard was: sensitivity 69%, specificity 95%, PPV 94%, NPV 75%, and accuracy 82%.
- In TB lymphadenitis, the MPT64 test performed best: sensitivity 79% and specificity 97% (n = 67). In paediatric TB (n = 41), sensitivity was 100% and specificity 96%.
- In TB cases, 65% of specimens were MPT64-positive versus 12% by ZN staining, 13% by culture, and 16% by Xpert; in specimens examined with all tests, MPT64 was positive in 81% versus 14%, 16%, and 16%, respectively.
## Methods
- Prospective study of patients with presumptive EPTB at Mnazi Mmoja Hospital, Zanzibar, enrolled from 1 Aug 2014 to 31 Aug 2015 and followed to end of treatment.
- Specimens from clinical sites were processed with routine diagnostics, GeneXpert MTB/RIF, and the MPT64 test; routine methods included ZN staining, culture, cytology/histology, and in some specimens Xpert.
- Diagnostic performance was assessed against a composite reference standard that categorized patients into TB and non-TB groups; sensitivity, specificity, PPV, NPV, and accuracy were calculated.
## Limitations
- Stated by the paper: the sample size was small, limiting subgroup analyses across all presumptive EPTB sites.
- Stated by the paper: not all patients/specimens underwent all routine diagnostic tests, which may have affected performance estimates for both the comparator tests and the MPT64 test.
- Stated by the paper: the composite reference standard may have reduced specificity because TB classification partly relied on clinical suspicion and response to anti-TB treatment.
- Evident from the text: only 20 HIV-positive patients were available, so the HIV subgroup findings are underpowered.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
4 Valid · 0 Not valid · 0 Not checked · 38 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The results are comparable with previous clinical studies performed in more controlled settings, especially for TB lymphadenitis [5, 25].”
§ MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar > Discussion
What the sources say
- Not checked — no full text of the sourcecites [5] MR Purohit, 2012, Rapid diagnosis of tuberculosis in aspirate, effusions, and cerebrospinal fluid by immunocytochemical detection of Mycobacterium tuberculosis complex specific antigen MPT64, Diagn Cytopathol source
- Partly supportedcites [25] A Tadele, 2014, Immunocytochemical detection of Mycobacterium Tuberculosis complex specific antigen, MPT64, improves diagnosis of tuberculous lymphadenitis and tuberculous pleuritis, BMC Infect Dis sourceExperimental — accuracy not yet measured
The Discussion (page unavailable in our copy) compares results with earlier studies, including a similar AFB positivity rate and comparable lymph-node culture positivity for TB lymphadenitis. It does not establish that those studies were performed in more controlled settings. (LLM, conf=0.83)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, in comparison to the composite reference standard for diagnosis, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the MPT64 test was 69%, 95%, 94%, 75% and 82%, respectively.”
§ MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar > Abstract > Results
plainn = 132- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In confirmed TB cases 83% of the specimens had a positive MPT64 test as compared to 67% positivity for culture and the Xpert assay.”
§ MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar > Results > MPT64 test performance compared to routine laboratory diagnostic tests and the Xpert assay
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In specimens examined with all diagnostic tests, the MPT64 test was positive in 81%, compared to 14%, 16% and 16% of the specimens showing a positive result with ZN staining, culture and the Xpert assay, respectively (Table 3).”
§ MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar > Results > MPT64 test performance compared to routine laboratory diagnostic tests and the Xpert assay
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, in comparison to the composite reference standard for diagnosis, the sensitivity, specificity, positive predictive value, negative predictive value and accuracy of the MPT64 test was 69%, 95%, 94%, 75% and 82%, respectively.”
§ MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar > Abstract > Results
plainn = 132- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
12 more claims
Create a free account to see all 42 claims and every source verdict.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 16
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is well known that ZN staining performs poorly in TBL samples [4, 10, 11, 13, 14, 16, 25].”
From Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, culture and Xpert MTB/RIF assays have been shown to have low sensitivity for TBL sample [4, 10, 11, 13, 14, 16, 25].”
From Improving diagnosis of tuberculous lymphadenitis by combination of cytomorphology and MPT64 immunostaining on cell blocks from the fine needle aspirates (2022) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“Similar observations have been described in other studies from TB endemic settings 12,27 and could be explained by the relatively small amount of material on FNAC leading to the granulomas present in the lymph node not being sampled.”
Citations
Cites
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Lawn, S. D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 458
Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413
Kumar, & Abbas (2016) · Cited by 410
Pai, M., Flores, L. L., Pai, N., Hubbard, A., Riley, L. W., & Colford, J. M. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00772-2 · Cited by 384
Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis?
Vadwai, V., Boehme, C., Nabeta, P., Shetty, A., Alland, D., & Rodrigues, C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02319-10 · Cited by 357
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
Chakravorty, S., Sen, M. K., & Tyagi, J. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4357-4362.2005 · Cited by 282
Pai, M., Flores, L. L., Hubbard, A., Riley, L. W., & Colford, J. M. (2004) · BMC Infectious Diseases · doi:10.1186/1471-2334-4-6 · Cited by 244
Cited by
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Yu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52
MPT64 assays for the rapid detection of Mycobacterium tuberculosis
Cao, X., Li, Y., Wang, J., Zhou, J., & Guo, X. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06022-w · Cited by 50
“For instance, Jorstad et al [21] analyzed the influence of age on diagnostic accuracy and found that the sensitivity of the MPT64 test was significantly higher in children than in adults.”
BackgroundMethodJørstad, M. D., Aßmus, J., Marijani, M., Sviland, L., & Mustafa, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203593 · Cited by 48
Self-citationDiagnosis of extra pulmonary tuberculosis: An update on novel diagnostic approaches
Jain, R., Gupta, G., Mitra, D. K., & Guleria, R. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107601 · Cited by 51
Metadata
- Authors
- Jørstad, M. D., Marijani, M., Dyrhol-Riise, A. M., Sviland, L., & Mustafa, T.
- Affiliations
- Haukeland University Hospital (NO)
- Government of Tanzania (TZ)
- Corresponding author
- Jørstad, Melissa Davidsen
- Marijani, Msafiri
- Sviland, Lisbet
- Mustafa, Tehmina
- Venue
- PloS one
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-05-09
- Volume
- 13
- Issue
- 5
- Pages
- e0196723
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5942825
- OpenAlex
- W2800589600
- Cited by
- 43
- References
- 32
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 4 · 2019: 4 · 2018: 2
- FWCI
- 3.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Norges Forskningsråd (234457)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- extrapulmonary tuberculosis, Mycobacterium tuberculosis, sensitivity and specificity, Xpert MTB/RIF, tuberculous lymphadenitis, pediatric tuberculosis, resource-limited settings, Zanzibar
- MeSH terms
- Adolescent, Adult, Antigens, Bacterial, Bacterial Proteins, Child, Developing Countries, Female, Humans, Immunohistochemistry, Lymph Nodes, Male, Middle Aged, Mycobacterium tuberculosis, Predictive Value of Tests, Prospective Studies, Surveys and Questionnaires, Sensitivity and Specificity, Tanzania, Tuberculosis, Tuberculosis, Lymph Node, HIV Infections, Comorbidity, Biopsy, Fine-Needle, Young Adult, Tertiary Care Centers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar. https://app.cochat.ai/papers/10.1371/journal.pone.0196723
- The paper
- Jørstad, M. D., Marijani, M., Dyrhol-Riise, A. M., Sviland, L., & Mustafa, T. (2018). MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar. PloS one. https://doi.org/10.1371/journal.pone.0196723
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.